Semaglutide ingredient can help protect kidney function in people with obesity: Study, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

​The remarkable secondary analysis from the SELECT (Semaglutide Effects on Heart Disease and Stroke in Patients with Overweight or Obesity) experiment, a randomised trial with a participant pool of 17,604 people, was unveiled by researchers today at the 61st ERA Congress., ​The remarkable secondary analysis from the SELECT (Semaglutide Effects on Heart Disease and Stroke in Patients with Overweight or Obesity) experiment, a randomised trial with a participant pool of 17,604 people, was unveiled by researchers today at the 61st ERA Congress., , Read More